PDS Biotechnology Corp SEC filings PDSB

PDS Biotechnology Corp has 795 filings in SEC EDGAR's recent list, going back to Sep 16, 2009. Its latest annual report, Form ARS, was filed on Jun 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.

PDS Biotechnology Corp SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 21, 2026 Oct 20, 2026
8-K Current report
Officer or director change, Other events
Oct 20, 2026 Oct 18, 2026
S-3 Shelf registration Oct 14, 2026 —
8-K Current report
Other events
Oct 6, 2026 Oct 6, 2026
8-K Current report
Other events
Sep 22, 2026 Sep 22, 2026
8-K Current report
Other events
Sep 21, 2026 Sep 21, 2026
8-K Current report
Agreement ended, Officer or director change, Regulation FD disclosure, Other events
Sep 14, 2026 Sep 12, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Sep 8, 2026 Sep 7, 2026
8-K Current report
Material agreement, New debt
Sep 4, 2026 Aug 31, 2026
8-K Current report
Exit or restructuring costs, Officer or director change
Aug 25, 2026 Aug 21, 2026
8-K Current report
Officer or director change
Aug 19, 2026 Aug 13, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Aug 14, 2026 Aug 10, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Regulation FD disclosure
Aug 11, 2026 Aug 11, 2026
8-K Current report
Listing notice
Jul 31, 2026 Jul 30, 2026
EFFECT Filing Jul 21, 2026 —
424B4 Prospectus Jul 21, 2026 —
S-3 Shelf registration Jul 10, 2026 —
ARS Annual report to shareholders Jun 26, 2026 Dec 31, 2025
DEFA14A Additional proxy material Jun 26, 2026 —
DEF 14A Proxy statement Jun 26, 2026 Aug 10, 2026
424B5 Prospectus supplement Jun 15, 2026 —
PRE 14A Preliminary proxy statement Jun 15, 2026 Aug 10, 2026
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Change to shareholder rights
Jun 15, 2026 Jun 15, 2026
8-K Current report
Other events
Jun 15, 2026 Jun 15, 2026
8-K Current report
Other events
Jun 2, 2026 Jun 2, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
May 1, 2026 Apr 30, 2026
EFFECT Filing Apr 28, 2026 —
10-K/A Amended annual report Apr 28, 2026 Dec 31, 2025
S-3/A Filing Apr 24, 2026 —
CORRESP Letter to the SEC Apr 24, 2026 —
8-K Current report
Other events
Apr 24, 2026 Apr 24, 2026
8-K Current report
Other events
Apr 15, 2026 Apr 15, 2026
10-K Annual report Mar 30, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 30, 2026 Mar 30, 2026
8-K Current report
Listing notice
Mar 3, 2026 Feb 25, 2026
8-K Current report
Other events
Feb 23, 2026 Feb 23, 2026
8-K Current report
Other events
Feb 20, 2026 Feb 20, 2026
8-K Current report
Other events
Jan 28, 2026 Jan 28, 2026
8-K Current report
Other events
Jan 22, 2026 Jan 22, 2026
8-K Current report
Other events
Jan 9, 2026 Jan 9, 2026
S-8 Employee stock plan registration Dec 12, 2025 —
8-K Current report
Other events
Dec 9, 2025 Dec 9, 2025
8-K Current report
Other events
Dec 2, 2025 Dec 2, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
Nov 12, 2025 Nov 11, 2025
424B5 Prospectus supplement Nov 12, 2025 —
8-K Current report
Other events
Nov 10, 2025 Nov 10, 2025
8-K Current report
Other events
Oct 29, 2025 Oct 29, 2025
8-K Current report
Other events
Sep 18, 2025 Sep 18, 2025
UPLOAD Letter from the SEC Sep 4, 2025 —
S-3 Shelf registration Aug 29, 2025 —
8-K Current report
Other events
Aug 25, 2025 Aug 25, 2025
8-K Current report
Other events
Aug 25, 2025 Aug 25, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 13, 2025 Aug 13, 2025
8-K Current report
Other events
Jul 10, 2025 Jul 10, 2025
8-K Current report
Other events
Jun 25, 2025 Jun 25, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2025 Jun 11, 2025
EFFECT Filing Jun 10, 2025 —
CORRESP Letter to the SEC Jun 6, 2025 —
8-K Current report
Other events
Jun 2, 2025 Jun 2, 2025
UPLOAD Letter from the SEC May 30, 2025 —
S-3 Shelf registration May 27, 2025 —
8-K Current report
Other events
May 22, 2025 May 22, 2025
DEFR14A Filing May 22, 2025 —
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
8-K Current report
Other events
May 8, 2025 May 8, 2025
DEFR14A Filing May 5, 2025 —
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
May 2, 2025 Apr 30, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 11, 2025
8-K Current report
Officer or director change
Apr 24, 2025 Apr 22, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
8-K Current report
Other events
Mar 13, 2025 Mar 13, 2025
8-K Current report
Other events
Mar 7, 2025 Mar 7, 2025
8-K Current report
Material agreement, Other events
Feb 28, 2025 Feb 26, 2025
424B5 Prospectus supplement Feb 28, 2025 —
8-K Current report
Other events
Feb 26, 2025 Feb 26, 2025
8-K Current report
Other events
Feb 24, 2025 Feb 24, 2025
8-K Current report
Other events
Feb 5, 2025 Feb 5, 2025
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations, Other events
Nov 14, 2024 Nov 14, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 2, 2024 Oct 2, 2024
8-K Current report
Other events
Sep 16, 2024 Sep 16, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 16, 2024 Sep 16, 2024
424B5 Prospectus supplement Aug 13, 2024 —
8-K Current report
Material agreement, Agreement ended
Aug 13, 2024 Aug 13, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
8-K Current report
Other events
Aug 8, 2024 Aug 8, 2024
8-K Current report
Other events
Aug 7, 2024 Aug 7, 2024
8-K Current report
Other events
Aug 5, 2024 Aug 5, 2024
8-K Current report
Other events
Aug 1, 2024 Aug 1, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 24, 2024 Jun 24, 2024
8-K Current report
Other events
Jun 12, 2024 Jun 12, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
8-K Current report
Other events
May 10, 2024 May 9, 2024
8-K Current report
Other events
May 8, 2024 May 8, 2024
8-K Current report
Officer or director change, Other events
May 2, 2024 May 1, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 24, 2024
PRE 14A Preliminary proxy statement Apr 18, 2024 Jun 24, 2024
S-8 Employee stock plan registration Mar 28, 2024 —
10-K Annual report Mar 28, 2024 Dec 31, 2023
8-K Current report
Results of operations, Other events
Mar 27, 2024 Mar 27, 2024
8-K Current report
Other events
Mar 13, 2024 Mar 13, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 22, 2024 Jan 22, 2024
8-K Current report
Other events
Dec 4, 2023 Dec 4, 2023
8-K Current report
Officer or director change, Other events
Nov 28, 2023 Nov 21, 2023
S-8 Employee stock plan registration Nov 14, 2023 —
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
8-K Current report
Other events
Nov 9, 2023 Nov 9, 2023
8-K Current report
Other events
Oct 23, 2023 Oct 23, 2023
8-K Current report
Other events
Oct 11, 2023 Oct 11, 2023
8-K Current report
Other events
Oct 3, 2023 Oct 3, 2023
8-K Current report
Other events
Oct 3, 2023 Oct 3, 2023
8-K Current report
Other events
Oct 3, 2023 Oct 3, 2023
8-K Current report
Other events
Oct 2, 2023 Oct 2, 2023
8-K Current report
Other events
Sep 20, 2023 Sep 20, 2023
8-K Current report
Other events
Sep 11, 2023 Sep 11, 2023
8-K Current report
Other events
Sep 8, 2023 Sep 6, 2023
8-K Current report
Other events
Aug 18, 2023 Aug 18, 2023
8-K Current report
Other events
Aug 17, 2023 Aug 16, 2023
8-K Current report
Other events
Aug 14, 2023 Aug 14, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Other events
Jul 25, 2023 Jul 25, 2023
8-K Current report
Other events
Jul 17, 2023 Jul 17, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jul 17, 2023 Jul 14, 2023
8-K Current report
Other events
Jul 11, 2023 Jul 11, 2023
8-K Current report
Other events
Jun 14, 2023 Jun 14, 2023
8-K Current report
Other events
Jun 14, 2023 Jun 14, 2023
ARS Annual report to shareholders Jun 2, 2023 Dec 31, 2022
DEFA14A Additional proxy material Jun 2, 2023 —
DEF 14A Proxy statement Jun 2, 2023 Jul 14, 2023
8-K Current report
Other events
Jun 1, 2023 Jun 1, 2023
8-K Current report
Other events
May 25, 2023 May 25, 2023
8-K Current report
Other events
May 25, 2023 May 25, 2023
8-K Current report
Other events
May 18, 2023 May 18, 2023
8-K Current report
Other events
May 17, 2023 May 17, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 15, 2023 May 15, 2023
10-K/A Amended annual report Apr 28, 2023 Dec 31, 2022
8-K Current report
Other events
Apr 27, 2023 Apr 27, 2023
8-K Current report
Other events
Apr 27, 2023 Apr 27, 2023
8-K Current report
Other events
Apr 24, 2023 Apr 24, 2023
8-K Current report
Other events
Apr 21, 2023 Apr 21, 2023
8-K Current report
Other events
Apr 12, 2023 Apr 12, 2023
8-K Current report
Other events
Apr 6, 2023 Apr 6, 2023
8-K/A Amended current report
Other events
Apr 3, 2023 Mar 30, 2023
8-K Current report
Results of operations
Mar 30, 2023 Mar 30, 2023
10-K Annual report Mar 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 28, 2023 Mar 28, 2023
8-K Current report
Other events
Mar 14, 2023 Mar 14, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 13, 2023
8-K Current report
Other events
Mar 1, 2023 Mar 1, 2023
8-K Current report
Other events
Feb 27, 2023 Feb 27, 2023
8-K Current report
Other events
Feb 16, 2023 Feb 16, 2023
8-K Current report
Other events
Feb 8, 2023 Feb 8, 2023
8-K Current report
Other events
Feb 6, 2023 Feb 6, 2023
8-K Current report
Other events
Jan 19, 2023 Jan 19, 2023
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 3, 2023 Dec 30, 2022
8-K Current report
Other events
Dec 28, 2022 Dec 28, 2022
8-K Current report
Other events
Dec 15, 2022 Dec 13, 2022
8-K Current report
Other events
Dec 12, 2022 Dec 12, 2022
8-K Current report
Other events
Nov 21, 2022 Nov 21, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations, Other events
Nov 14, 2022 Nov 14, 2022
8-K Current report
Other events
Nov 7, 2022 Nov 7, 2022
8-K Current report
Other events
Oct 27, 2022 Oct 27, 2022
8-K Current report
Other events
Oct 27, 2022 Oct 26, 2022
8-K Current report
Other events
Oct 17, 2022 Oct 17, 2022
8-K Current report
Other events
Oct 12, 2022 Oct 12, 2022
8-K Current report
Other events
Oct 11, 2022 Oct 11, 2022
8-K Current report
Other events
Oct 5, 2022 Oct 5, 2022
8-K Current report
Other events
Oct 3, 2022 Sep 28, 2022
8-K Current report
Other events
Sep 21, 2022 Sep 21, 2022
EFFECT Filing Sep 2, 2022 —
CORRESP Letter to the SEC Aug 30, 2022 —
UPLOAD Letter from the SEC Aug 29, 2022 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Aug 24, 2022 Aug 24, 2022
S-8 Employee stock plan registration Aug 24, 2022 —
S-3 Shelf registration Aug 24, 2022 —
8-K Current report
Other events
Aug 10, 2022 Aug 10, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
8-K Current report
Other events
Aug 4, 2022 Aug 4, 2022
8-K Current report
Other events
Jul 14, 2022 Jul 14, 2022
8-K Current report
Shareholder vote results
Jun 16, 2022 Jun 15, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PDSB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Princeton, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1472091
Former names
Edge Therapeutics, Inc. (until Mar 18, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.